Star Peak Corp. II (NYSE:STPC) announced in an 8-K filing this morning that its shareholders approved its combination with food technology company Benson Hill at a shareholder vote held yesterday, but saw significant redemptions like many of its peers this month.
A total of 30,781,843 shares were redeemed in connection with its vote, removing about 76.5% of its roughly $402 million trust going into the vote. But, together with the transaction’s $225 million PIPE, Star Peak II cleared the minimum cash condition of the deal with room to spare.
The parties expect to close the transaction later today with the combined company’s shares and warrants set to begin trading on the NYSE under the symbols “BHIL” and “BHIL WS”, respectively, on September 30
Star Peak II originally announced its $1.35 billion combination with Benson Hill on May 10. St. Louis, Missouri-based Benson Hill develops enhanced crops to produce plant-based protein food ingredients and sells fresh produce to grocery networks like Kroger (NYSE:KR) and US Foods (NYSE:USFD).
For a description of other measures on the Star Peak II ballot and full vote tallies, click HERE.
ADVISORS
- Goldman Sachs & Co. LLC and Credit Suisse Securities (USA) LLC are serving as joint financial advisors and capital markets advisors to Star Peak and as co-placement agents on the PIPE offering.
- Kirkland & Ellis LLP is serving as legal advisor to Star Peak.
- Barclays is serving as exclusive financial advisor and capital markets advisor to Benson Hill, as well as co-placement agent on the PIPE offering.
- Winston & Strawn LLP is serving as legal advisor to Benson Hill
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...